良性阵发性位置性眩晕循证实践实施:DIZZTINCT阶梯楔形随机试验方案
本研究为阶梯楔形随机临床试验方案,针对急诊头晕就诊的良性阵发性位置性眩晕(BPPV)患者,以医院为随机单位实施多维度教育与照护流程干预,旨在提高指南一致的Dix-Hallpike试验(DHT)和管石复位手法(CRM)记录率,主要终点为患者层面DHT或CRM记录的存在。
要点
- 以医院为随机单位,6家医院分5波次交叉实施干预。
- 主要终点为患者层面DHT或CRM的记录存在。
- 次要终点包括转诊至合格眩晕诊疗提供者及90天卒中率。
核心结论
- 若研究安全地提高DHT/CRM记录率,将是实施这些循证照护流程的重要一步。
- 阳性结果将支持开展更大规模随访研究以评估患者结局。
研究设计与样本
- 阶梯楔形随机临床试验,以医院为随机单位和干预目标。
- 6家医院在初始观察期后分5波次接受干预,顺序随机,两家紧密整合的医院配对。
- 主要终点在个体患者层面测量,为DHT或CRM记录的存在。
主要发现
- BPPV是常见外周前庭疾病,占中度或重度头晕个体的8%。
- DHT是BPPV的金标准测试,CRM得到众多随机对照试验和系统评价支持。
- 尽管有指南级证据,BPPV照护流程利用不足。
关键数值与推荐
- DHT为BPPV金标准测试,CRM(常用改良Epley手法)获指南级证据支持。
临床怎么用
- 干预为多维度教育与照护流程相结合,旨在改善急诊头晕BPPV患者的指南一致照护。
- 次要终点包括转诊至有资格治疗头晕的提供者进行CRM及急诊头晕就诊后90天卒中率。
局限性
- 为研究方案,尚未报告实施效果或患者结局数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Benign paroxysmal positional vertigo (BPPV) is the most common peripheral vestibular disorder, and accounts for 8% of individuals with moderate or severe dizziness. BPPV patients experience substantial inconveniences and disabilities during symptomatic periods. BPPV therapeutic processes - the Dix-Hallpike Test (DHT) and the Canalith Repositioning Maneuver (CRM) - have an evidence base that is at the clinical practice guideline level. The most commonly used CRM is the modified Epley maneuver. The DHT is the gold standard test for BPPV and the CRM is supported by numerous randomized controlled trials and systematic reviews. Despite this, BPPV care processes are underutilized. METHODS/DESIGN: This is a stepped-wedge, randomized clinical trial of a multi-faceted educational and care-process-based intervention designed to improve the guideline-concordant care of patients with BPPV presenting to the emergency department (ED) with dizziness. The unit of randomization and target of intervention is the hospital. After an initial observation period, the six hospitals will undergo the intervention in five waves (two closely integrated hospitals will be paired). The order will be randomized. The primary endpoint is measured at the individual patient level, and is the presence of documentation of either the Dix-Hallpike Test or CRM. The secondary endpoints are referral to a health care provider qualified to treat dizziness for CRM and 90-day stroke rates following an ED dizziness visit. Formative evaluations are also performed to monitor and identify potential and actual influences on the progress and effectiveness of the implementation efforts. DISCUSSION: If this study safely increases documentation of the DHT/CRM, this will be an important step in implementing the use of these evidenced-based processes of care. Positive results will support conducting larger-scale follow-up studies that assess patient outcomes. The data collection also enables evaluation of potential and actual influences on the progress and effectiveness of the implementation efforts. TRIAL REGISTRATION: ClinicalTrials.gov, ID: NCT02809599 . The record was first available to the public on 22 June 2016 prior to the enrollment of the first patients in October 2016.
引用
- Meurer WJ, Beck KE, Rowell B, et al. Implementation of evidence-based practice for benign paroxysmal positional vertigo: DIZZTINCT- A study protocol for an exploratory stepped-wedge randomized trial. Trials. 2018. PMID: 30577834. doi:10.1186/s13063-018-3099-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。